| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.004 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.094 | 0.004 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.2 | 0.005 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.005 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.005 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.006 |